MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology
about
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research.Recent advances in the imaging of frontotemporal dementia.Proton MRS in mild cognitive impairment.Magnetic resonance spectroscopy in Alzheimer's disease.Magnetic resonance spectroscopy in common dementiasClinical proton MR spectroscopy in central nervous system disordersAltered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTDMagnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study.The non-fluent/agrammatic variant of primary progressive aphasia.MRS in early and presymptomatic carriers of a novel octapeptide repeat insertion in the prion protein gene.Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylationAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathyRegional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.Presymptomatic studies in genetic frontotemporal dementia.Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.Longitudinal magnetic resonance spectroscopy as marker of cognitive deterioration in mild cognitive impairment.
P2860
Q30485675-FE3F1995-F912-4E53-B4E6-AE11D62D5BD6Q30570862-3F881968-8CBE-46FA-85CB-ACA5E1164106Q30606675-63E37754-1095-4528-A572-185D199654DDQ30630699-1FBAEF18-841F-4FFA-9B1A-D256F6723133Q30660402-BFA0DB9E-1E20-4ECC-B501-B5D21DE9D57CQ30764446-2E7D5EBF-54DD-43FA-9DD8-FEBD44074481Q35183555-5D8A20C2-87F4-4FDA-8866-2908347BBEB9Q35319467-21B4E662-E17E-48C7-A3CE-B15B49A44C05Q35992776-A8079A54-6146-44B7-8DAF-353161C92F7CQ36345364-1F30C7C2-F5D6-4846-9DE5-D7B8A5F3313BQ36840001-5389A472-4FE4-483C-AB70-E946DCD81453Q37084011-6B3FCFDB-DA6F-4D95-9E18-FF99FDE4298DQ37652823-D8AB75CD-1336-47E1-A8CF-5B8A233D376AQ38135140-B716D0FE-1039-46AC-8A3E-EA4FDB8692E6Q44937365-0A781EB5-FEED-4900-AA8F-A83521625C1FQ48665796-02A30C63-CB8C-444C-8F27-77358A9272C2
P2860
MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@ast
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@en
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@nl
type
label
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@ast
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@en
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@nl
prefLabel
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@ast
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@en
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@nl
P2093
P2860
P50
P1433
P1476
MRS in presymptomatic MAPT mut ...... ker for tau-mediated pathology
@en
P2093
A R Samikoglu
D S Knopman
J L Whitwell
M L Senjem
R C Petersen
R Rademakers
P2860
P304
P356
10.1212/WNL.0B013E3181F073C7
P407
P577
2010-08-01T00:00:00Z